{
    "nctId": "NCT03381963",
    "briefTitle": "Hemostatic Profiles of Endocrine Therapies for Breast Cancer",
    "officialTitle": "Hemostatic Profiles Associated With Use of Aromatase Inhibitors and Tamoxifen in Women With Breast Cancer : a Prospective Cohort Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Venous Thromboembolism",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Change in thrombin generation, including APC sensitivity ratio",
    "eligibilityCriteria": "Inclusion Criteria: adult women with a diagnosis of non-metastatic breast cancer and an indication for adjuvant endocrine therapy\n\nExclusion Criteria:\n\n* lack of consent\n* planned chemotherapy\n* personal history of venous thromboembolism\n* ongoing anticoagulant treatment",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}